Citadel Advisors
GMDA

Citadel Advisors’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Citadel Advisors’s Portfolio GMDA Stock Details GMDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-29,600
Closed -$1.07K – 15856
2024
Q1 		$1.07K Buy
29,600
+9,400
+47% +$3.21K ﹤0.01% 14189
2023
Q4 		$8.34K Buy
20,200
+10,300
+104% +$5.82K ﹤0.01% 13226
2023
Q3 		$10.2K Sell
9,900
-4,800
-33% -$6.13K ﹤0.01% 13079
2023
Q2 		$28.4K Buy
14,700
+12,000
+444% +$20.7K ﹤0.01% 12414
2023
Q1 		$2.19K Sell
2,700
-1,900
-41% -$2.78K ﹤0.01% 14190
2022
Q4 		$5.93K Buy
+4,600
New +$7.27K ﹤0.01% 13955
2022
Q2 		– Sell
-46,200
Closed -$192K – 14446
2022
Q1 		$192K Buy
46,200
+4,200
+10% +$14.1K ﹤0.01% 11590
2021
Q4 		$107K Buy
42,000
+18,600
+79% +$61.3K ﹤0.01% 12656
2021
Q3 		$92K Sell
23,400
-20,200
-46% -$101K ﹤0.01% 12963
2021
Q2 		$279K Buy
43,600
+7,000
+19% +$48.3K ﹤0.01% 11447
2021
Q1 		$296K Buy
+36,600
New +$336K ﹤0.01% 10890

Other funds holding GMDA

PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citadel Advisors's GMDA Position: Q2 2024 in Review

Citadel Advisors sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q2 2024, closing a stake of 18,890 shares — an estimated $682 sold.

Citadel Advisors first reported a position in GMDA in Q3 2020 and held it in 10 quarters. The position peaked at $381K in Q1 2021. 2 funds tracked by Wall St. Rank hold GMDA as of Q2 2024.

  • Citadel Advisors reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 18,890 Gamida Cell Ltd. Ordinary Shares shares in Q2 2024, an estimated $682.
  • Citadel Advisors first reported a position in Gamida Cell Ltd. Ordinary Shares in Q3 2020 and held it in 10 quarters.
  • Citadel Advisors's Gamida Cell Ltd. Ordinary Shares position peaked at $381K in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.